论文信息 - Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy - 字舞流文

Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy

T. Hardin | T. Ritter | L. V. Anglen | Chris Fourment | Lucinda J. Van Anglen | T. C. Okoro